A private gathering for 100 of EMEA’s most influential technical leaders shaping the future of AI, HPC and data infrastructure in Life Sciences.
This year, WEKA is convening 100 of the most senior technology decision-makers across EMEA — CTOs, HPC, AI and ML architects, and infrastructure executives working at the frontier of scientific innovation. Co-hosted with Boston Limited, a leading UK provider of high-performance server, storage and networking solutions, this exclusive forum brings together the leaders defining what comes next.
The Core 100 event is deliberately designed as a closed, peer-level forum. Intimate regional roundtables. No sales pitches. No generic panels. Just senior leaders engaging in candid discussion about the high-performance infrastructure decisions that will shape the future of Life Sciences.
A closed-door forum built for real conversation
The Core 100 is intentionally designed as a peer-level environment for open, candid exchange. No sales pitches. No generic panels. No junior attendees. Just senior leaders sharing practical insight on the infrastructure decisions that will determine the next era of Life Sciences innovation.
Through intimate regional roundtables, attendees will engage in focused discussions on the challenges, trade-offs and strategic bets shaping high-performance computing and AI infrastructure today.
Can your infrastructure keep pace with your science?
Life Sciences workloads are some of the most demanding in modern computing. Genome sequencing pipelines, structural biology simulations, digital twins and generative biology are producing data at a scale that legacy architectures were never built to support. The result is familiar: bottlenecks, inefficiencies and delays that slow research, discovery and time to impact.
The question is simple:
Does your data infrastructure move at the speed your science demands?
Join WEKA and Boston Limited in London on June 11th for a private gathering of AI and technology leaders shaping the next generation of infrastructure across Europe, where we will explore how modern AI and HPC environments are being architected for performance, agility and sovereign control — and what that means for Life Sciences organisations operating at scale.
